<DOC>
	<DOCNO>NCT02591355</DOCNO>
	<brief_summary>Platelet rich plasma ( PRP ) therapy novel therapeutic modality see broad application number medical indication include orthopedics , dentistry , dermatology . In dermatology , use included treatment chronic wound facial rejuvenation . More recently , anecdotal report suggest efficacy treatment hair loss , best knowledge , one publish case series document use indication .</brief_summary>
	<brief_title>Evaluate Clinical Effectiveness RegenKit Platelet-rich Plasma ( PRP ) Androgenetic Alopecia Treatment</brief_title>
	<detailed_description>This study design well assess efficacy PRP hair loss , therefore propose study interval intralesional PRP injection patient androgenetic alopecia ( AGA ) . Androgenetic alopecia common form hair loss world-wide . Although currently numerous treatment option indication include minoxidil , 5-alpha reductase inhibitor follicular unit transplant , many medical treatment option undesirable side effect , particularly woman child bear age . These well-documented adverse reaction include impotency , hypertrichosis , birth defect .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Men woman , age 1860 AGA Completed inform consent form Ludwig stage 12 woman Norwood Hamilton Stage 3 5 men Pregnancy breastfeed Younger 18 year Uses minoxidil and/or 5alpha reductase inhibitor ( finasteride dutasteride ) within 3 month enrol study History hair transplantation Use cosmetic product aim improve correct sign hair loss within 2 week prior screen Facial cancer ( squamous basal cell carcinoma , melanoma ) Hereditary acquire hematologic/coagulation disorder : platelet dysfunction syndrome , critical thrombocytopenia , hypofibrinogenemia , impaired coagulation , drepanocytosis ( sickle cell anemia ) . Hemodynamic instability Acute infection Autoimmune disease Hashimoto , rheumatoid arthritis , lupus ( exception : vitiligo alopecia areata ) Malignancy without metastatic disease Chemotherapy Dermatological diseases affect face ( e.g . porphyria ) Anticoagulant therapy Patients take Aspirin NSAIDs ( Nonsteroidal antiinflammatory drug ) Nurofen , Voltaren , Diclofenac Naproxen participate , provide medication interrupt 7 day begin treatment Patients take vitamin E supplement participate , provide medication interrupt 14 day begin treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Platelet Rich Plasma</keyword>
	<keyword>Hair Loss</keyword>
</DOC>